Resources
3 Results (showing 1 - 3)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 7/25/2022 (updated 3/27/2024)
In 2019, the Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington launched the “Meds First” program to provide onsite, low-barrier access to buprenorphine in partnership with six syringe services programs across WA State. A key component of the Meds First service model was the addition of care navigation to support client engagement and retention in OUD treatment.
Expanding The Circle of Care: A Practical Guide to Syringe Services for Tribal and Rural Communities
Posted 8/3/2021 (updated 4/2/2024)
This guide presents practical information on establishing and maintaining syringe services in rural and tribal communities based on experiences of the Bad River Band of Lake Superior Chippewa.
Posted 12/29/2020 (updated 4/4/2024)
Whereas outpatient treatment with medication for opioid use disorder (MOUD) is evidence based, there is a large network of inpatient facilities in the US that are reimbursed by commercial insurers and do not typically offer MOUD. This study is a comparison of rates of overdose and hospitalization after initiation of medication for Opioid Use Disorder in the inpatient vs outpatient setting.